https://multiplesclerosisnewstoday.com/news-posts/2020/09/08/msvirtual2020-atara-biotherapeutics-ata188-safe-early-efficacy-signs-seen-progressive-ms-phase-1-trial/?utm_source=Multiple+Sclerosis&utm_campaign=1db9e73045-RSS_NON-US_EMAIL_CAMPAIGN&utm_medium=email&utm_term=0_b5fb7a3dae-1db9e73045-71353521
ATA188, Atara Biotherapeutics’ investigative T-cell immunotherapy, is safe, well tolerated, and able to ease disability and improve exercise capacity in patients with progressive forms of multiple...
multiplesclerosisnewstoday.com
Get replies from creators like gasconi1962
